Poland· PL-100289440
Nitroxolin forte
A nitroxoline product containing nitroxolinum, registered in Poland by MIP Pharma Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nitroxoline is registered in 2 of 19 countries.
Countries holding a registration under ATC J01XX07 (nitroxoline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 1 of them publish a price we can compare per daily dose
Nitroxoline · ATC J01XX07
2 / 19 countries
- Germany
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Nitroxolinum
- Manufacturer
- MIP Pharma Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J01XX07
- ATC class
- Nitroxoline
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991022761
- gtin05909991022778
- gtin05909991022785
- gtin05909991419974
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nitroxoline in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Нитроксолин Форте Mip
- Germany · Nilox Midi, Nilox Mini
- Croatia · Nitroxolin Forte Mip Pharma Croatia D.O.O.
- Romania · Nitroxolină Mip
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5416ad10-a0c8-45c7-b665-41b30471f4f2 GET /v1/drugs/5416ad10-a0c8-45c7-b665-41b30471f4f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki miękkie",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909991022761 ¦ Rp ¦ 80649\n10 kaps.\n05909991022778 ¦ Rp ¦ 80650\n30 kaps.\n05909991022785 ¦ Rp ¦ 80651\n90 kaps.\n05909991419974 ¦ Rp ¦ 134843\n20 kaps.",
"substance": "Nitroxolinum 250 mg",
"common_name": "Nitroxolinum",
"pl_product_id": "100289440",
"pozwolenie_nr": "20668",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about nitroxoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.